Cantor Fitzgerald Predicts FATE FY2026 Earnings
Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for shares of Fate Therapeutics in a note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst L. Watsek forecasts that the biopharmaceutical company will post earnings of ($0.73) per share for the […]
Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for shares of Fate Therapeutics in a note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst L. Watsek forecasts that the biopharmaceutical company will post earnings of ($0.73) per share for the […]
